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Background: Symptomatic osteoarthritis poses a major challenge to primary health care but no studies
have related accessing primary care (‘detection’), receiving recommended treatments (‘treatment’), and
achieving adequate control (‘control’).
Objective: To provide estimates of detection, treatment, and control within a single population adapting
the approach used to determine a Rule of Halves for other long-term conditions.
Setting: General population.
Participants: 400 adults aged 50þ years with prevalent symptomatic knee osteoarthritis.
Design: Prospective cohort with baseline questionnaire, clinical assessment, and plain radiographs, and
questionnaire follow-up at 18 and 36 months and linkage to primary care medical records.
Outcome measures: ‘Detection’ was defined as at least one musculoskeletal knee-related GP consul-
tation between baseline and 36 months. ‘Treatment’ was self-reported use of at least one recom-
mended treatment or physiotherapy/hospital specialist referral for their knee problem at all three
measurement points. Pain was ‘controlled’ if characteristic pain intensity <5 out of 10 on at least two
occasions.
Results: In 221 cases (55.3%; 95%CI: 50.4, 60.1) there was evidence that the current problem had been
detected in general practice. Of those detected, 164 (74.2% (68.4, 80.0)) were receiving one or more of the
recommended treatments at all three measurement points. Of those detected and treated, 45 (27.4%
(20.5, 34.3)) had symptoms under control on at least two occasions. Using narrower definitions resulted
in substantially lower estimates.
Conclusion: Osteoarthritis care does not conform to a Rule of Halves. Symptom control is low among
those accessing health care and receiving treatment.
 2014 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.Introduction
Inadequate detection, treatment, and control e “medical science
un-applied”1 e are recurrent concerns in the management of most
chronic conditions. An intriguing finding in previous studies of hy-
pertension, hypercholesterolaemia, diabetes, lower respiratory tract
infections, asthma, and epilepsy has been a Rule of Halves in which: G. Peat, Arthritis Research
ary Care & Health Sciences,
l: 44-1782-733906; Fax: 44-
h), Barbara.Nicholl@glasgow.
reen), j.bedson@keele.ac.uk
ternational. Published by Elsevier L“approximately half of most common chronic disorders are unde-
tected, that half of those detected are not treated, and that half of
those treated are not controlled”2. Yet this is not a fixed law: incen-
tivising care and aggressive use of effective medication are credited
with surpassing theRule ofHalves inmanaginghighbloodpressure3.
Taken together, reports of prolonged non-consultation, under-
use of recommended treatments and inadequate control of symp-
tomatic osteoarthritis appear to reflect similar concerns to those
behind the Rule of Halves, although it appears not have to been
looked at in this way before. We therefore sought to estimate
detection, treatment, and control of symptomatic knee osteoar-
thritis within a defined cohort. Low expectations, lack of incentives
for care, and conservative treatments that rely on behavioural
change to achieve small-to-moderate benefits, might suggest that
current care for osteoarthritis would not exceed the Rule of Halves.td. All rights reserved.
L. Sheikh et al. / Osteoarthritis and Cartilage 22 (2014) 535e539536Methods
Participants
Participants were members of the Knee Clinical Assessment
Study (CAS-K), a prospective observational cohort study of knee
pain and osteoarthritis in the general population. Ethical approval
for the study was obtained from North Staffordshire Research
Ethics Committee (References: 1430, 03/94, 05/Q2604/72) and the
study protocol has been published4. Briefly, all patients aged 50
years registered with three general practices in North Staffordshire
were invited to take part in a two-stage postal survey. Respondents
who answered positively to ‘knee pain in the last year’ were invited
to attend a research clinic which included clinical interview, plain
X-rays and a self-complete questionnaire. At 18-months research
clinic attenders completed a mailed self-complete questionnaire
and were contacted again at 3-years with a questionnaire and
invitation to research clinic as per baseline. The medical records of
consenting participants were searched using an algorithm based on
diagnosis/problem code entries and free text entries with all po-
tential hits hand-searched for evidence of musculoskeletal knee-
related GP consultations between baseline and 3-year follow-up.
Inclusion criteria for the current analysis were: knee symptoms
on few days or more in the past month at baseline and at least
definite osteophytes on plain radiographs of the index knee in
either tibiofemoral or patellofemoral joint (equivalent to Kellgren &
Lawrence grade 2 or more)5. Participants with a pre-existing
diagnosis of inflammatory arthropathy, a total knee replacement
in their most troublesome knee at baseline, or who were lost to
follow-up at 3-years were excluded.Definitions of detection, treatment, and control
The specific definitions used in the current study for detection,
treatment, and control are provided in Table I. In the absence of any
well-accepted definitions of what constitutes ‘detection’, adequate
‘treatment’, and satisfactory symptom ‘control’ of osteoarthritis we
adopted broad definitions of these and then undertook sensitivity
analyses to explore the effects on estimates of using narrower
definitions for each of these three concepts. The broader definitions
are described below: the narrower definitions appear in Table I.
For ‘detection’ our choice of a 3-year period represented a
middle ground between a definition based on lifetime consultationTable I
Definitions of cases, detection, treatment, and control
Broad definition
Case definition Knee symptoms on few days or more in the past month at time
of research assessment clinic visit at baseline and evidence of at
least definite osteophytes on plain radiographs of the index
knee in either tibiofemoral or patellofemoral joint (equivalent
to Kellgren & Lawrence grade 2 or more)
Detection At least one recorded knee-related musculoskeletal general
practice consultations in the 3-year period following baseline
OR self-reported recall of knee-related general practice
consultation in the 3-year period following baseline
Treatment Self-report of having been seen by a physiotherapist or hospital
specialist for their knee problem, received a TKR, or receiving at
least one of the following recommended6 treatments at baseline
AND 18-months AND 3-years: dieting to lose weight (if body
mass index  25 kg/m2), specific knee exercises, paracetamol,
oral NSAID (including COX2 inhibitor), oral opioid analgesia,
topical analgesics/NSAID, or intra-articular injection)
Control Self-reported characteristic pain intensity in the past 6 months7
of <5 out of 108 at two out of the three measurement points
(baseline, 18-months, 3-years)(‘ever seen your doctor about your problem’), which may not cap-
ture GPs’ awareness of their patients’ current status, and a defini-
tion based on consultationwithin only 1 year, which, although used
as the basis in some quality of care indicators10 may be too short an
interval for monitoring a condition in which dramatic changes are
rare. The definition of treatment meant that participants could
switch treatments during the 3-year time period. However, at each
of the three measurement points they had to be receiving at least
one form of recommended treatment (see Table I). Treatments
were counted irrespective of dose and source of supply. The in-
clusion of referral to physiotherapy or hospital specialist was
intended to capture other potential recommended treatments that
participants had received or may be taking but which had not been
included as individual items in the treatment checklist of the
questionnaires (e.g., bracing, TENS, manual therapy). Information
on treatment was by participant self-report due to the absence or
incomplete recording in the routine medical record of many rec-
ommended treatments. A participant’s pain was considered
‘controlled’ if on at least two of the three measurement points they
reported characteristic pain intensity in the past 6 months7 of <5
out of 108. If this criterionwas not met, then the painwas classed as
‘uncontrolled’.
Data analysis
The estimated rates of detection, treatment (among detected
cases), and control (among detected and treated cases) were
expressed as simple proportions with 95% confidence intervals
(95%CI). Sensitivity analyses were run, repeating the above analyses
but using the narrow definitions (Table I) in isolation and then in
combination. We also investigated the effect of raising the symp-
tom threshold for case definition at baseline to symptoms on most
or all days in the past month. All datawere analysed using Stata 11.0
(StataCorp. 2009. Stata Statistical Software: Release 11. College
Station, TX: StataCorp LP).
Results
400 participants were included in the analysis (48% female;
mean age 66.9 years (SD 8.6; range 50e93); mean average pain
intensity in past 6 months 4.6 (SD 2.4)). Reasons for exclusionwere:
patient declined radiography (n ¼ 2), TKR index knee (n ¼ 15),Narrow definition
Knee symptoms on most or all days in the past month at time of research
assessment clinic visit at baseline and evidence of at least definite osteophytes
on plain radiographs of the index knee in either tibiofemoral or patellofemoral
joint (equivalent to Kellgren & Lawrence grade 2 or more)
At least one recorded knee-related musculoskeletal general practice
consultation, specifically coded as osteoarthritis (Read codes N05 or N06), in
the 3-year period following baseline
Self-report of receiving at least one of the following recommended core
nonpharmacological treatments at baseline AND 18-months AND 3-years:
dieting to lose weight (if body mass index  25 kg/m2), specific knee exercises
Self-reported characteristic pain intensity in the past 6 months of <4 out of 109
at two out of the three measurement points (baseline, 18-months, 3-years)
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matory disease (n¼ 16), no knee symptoms in past month reported
at baseline clinic (n ¼ 56), no radiographic osteoarthritis in index
knee (n ¼ 215), died between baseline and 3-year follow-up
(n ¼ 12), lost to follow-up at 3-years (n ¼ 59), and missing data
(n ¼ 35).
The Rule of Halves
Using the broad definitions, the estimated rates of ‘detection’,
‘treatment’ and ‘control’ were 55.3% (95%CI: 50.4, 60.1), 74.2% (68.4,
80.0), and 27.4% (20.5, 34.3) respectively (Table II).
Rates of ‘detection’ and ‘treatment’ were slightly higher and
‘control’ substantially lower when the analysis was restricted to
patients with frequent symptoms at baseline (67.2%, 81.7% and
15.9% respectively). The requirement of having received a GP
recorded diagnosis of osteoarthritis halved the ‘detection’ estimate
(from 55.3% to 23.3%) but made little difference to the estimated
rates of ‘treatment’ or ‘control’. Using the narrow definition for
treatment, which insisted on core nonpharmacological treatment
(dieting or knee exercises) at all three time points substantially
reduced the ‘treatment’ estimate (from 74.2% to 17.2%) but with
little effect on ‘control’. Choosing the more stringent Patient
Acceptable Symptom State (PASS) criterion9 (Table I) reduced the
‘control’ estimate from 27.4% to 18.3%. Of 195 persons with symp-
tomatic radiographic knee osteoarthritis and frequent symptoms at
baseline, we found only one who had evidence of an osteoarthritis-
coded GP consultation over the 3-year period, consistent use of core
nonpharmacological treatment, and symptoms that were classed as
‘controlled’ using the PASS cut-off.
Discussion
Our findings suggest that the management of symptomatic knee
osteoarthritis does not conform to a Rule of Halves. Our sensitivity
analyses, using more stringent definitions that were still consistent
with current recommendations, suggest that rates of detection,
treatment, and control are, if anything, likely to be lower.
Our estimate of 55% detection is at the slightly higher end
compared with previous studies11. The inclusion of both self-
reported recall and electronic health record as sources for consul-
tation in the present study could partially explain the higherTable II
Estimated rates of detection, treatment and control in community-dwelling individuals
N Detection
Broad definitions 400 221
55.3% (50
Sensitivity analyses:
[A] Narrow case definition 195 131
67.2% (60
[B] Narrow definition of detection 400 93
23.3% (19
[C] Narrow definition of treatment 400 221
55.3% (50
[D] Narrow definition of control 400 221
55.3% (50
[A]þ[B] 195 58
29.7% (23
[A]þ[B]þ[C] 195 58
29.7% (23
[A]þ[C]þ[D] 195 131
67.2% (60
[A]þ[B]þ[C]þ[D] 195 58
29.7% (23
NB Numbers and percentages are within those with complete data for each calculation.
See Table I for definitions.estimate. More fundamentally, ‘detection’ was defined simply as
evidence of a general practitioner consultation and rates of treat-
ment and control differed little depending onwhether knee-related
consultations were recorded under the diagnosis of knee osteoar-
thritis or under non-specific symptom codes. Prioritising higher
consultation rates and disease diagnosis may be less important
than implementing timely, accurate ‘detection’ of patients’ pain
severity and functional limitation. These are currently poorly
recorded12 but consistently proposed quality of care indicators10,13.
Our unit is currently evaluating simple computer prompts and
intensive training and support of practitioners to improve
implementation.
On treatment and control, again our findings are broadly
consistent with previous studies showing fairly high rates of use of
recommended pharmacological treatments, relatively low levels of
use of recommended nonpharmacological treatments, and often a
lack of adequate symptom control in spite of these12,14e19. Our
study cannot determine the respective contributions of mis-
matching existing treatments to patients, inadequate dosage and
duration20, and reduced effectiveness of treatments when applied
to the broader spectrum of patients in routine practice than typi-
cally included in clinical trials21. Improving access to allied health
professionals in primary care22 and the long-term maintenance of
effective nonpharmacological treatments warrant continued
research and service development.
Our sample was drawn from prevalent symptomatic individuals
recruited to an existing population cohort with linked medical re-
cord review. This approach enabled us to define cases based on the
combination of symptoms and evidence of structural changes
rather than by symptoms alone, and to use prospectively collected
data thereby reducing inaccurate recall. However, although our
sample was derived from a census survey of the entire population
aged 50 years and over registered with participating practices, non-
response and attrition may potentially bias estimates. We previ-
ously investigated patterns of selective participation and loss to
follow-up in this cohort and found that aged 80 years and over,
lower socioeconomic group, currently in employment, experi-
encing anxiety or depression, and brief episode of knee painwithin
the previous year were associated with non-participation at base-
line23. The net effect of this on our estimates is difficult to judge.
While our study gathered a large amount of data, it was on a
relatively small sample from a single geographical region. Estimateswith symptomatic knee osteoarthritis, North Staffordshire, 2002e2006
Treatment Control
.4, 60.1)
164
74.2% (68.4, 80.0)
45
27.4% (20.5, 34.3)
.5, 73.8)
107
81.7% (75.0, 88.4)
17
15.9% (8.8, 22.9)
.1, 27.4)
69
74.2% (65.1, 83.3)
15
21.7% (11.8, 31.7)
.4, 60.1)
38
17.2 % (12.2, 22.2)
8
21.1% (7.5, 34.6)
.4, 60.1)
164
74.2% (68.4, 80.0)
30
18.3% (12.3, 24.3)
.3, 36.2)
47
81.0% (70.6, 91.4)
7
14.9% (4.3, 25.5)
.3, 36.2)
12
20.7% (9.9, 31.4)
1
8.3% (0.0, 26.7)
.5, 73.8)
26
19.8% (12.9, 26.8)
2
7.7% (0.0, 18.7)
.3, 36.2)
12
20.7% (9.9, 31.4)
1
8.3% (0.0, 26.7)
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some extent. The period of observation preceded the publication of
NICE guidelines for the management of osteoarthritis in 2008 and
patterns of treatment may have changed. However, many system-
atic reviews and guidelines with overlapping content to the NICE
guidelines existed at the time of the study24 and we have previ-
ously shown that rates of prescribed analgesia in this population
(with the possible exception of topical NSAIDs) are unlikely to have
changed markedly25.
Applying the concepts underpinning the Rule of Halves to
symptomatic osteoarthritis raises many questions. Unlike asymp-
tomatic conditions, symptomatic osteoarthritis is in practice a
clinical syndrome and the main consequences e pain and func-
tional limitation e are manifest to the patient; therefore rates of
detection, treatment, and control in general practice will reflect, in
part at least, the values and informed choices of patients, including
making an informed decision to self-manage or to live with pain
without treatment. The two cutoffs we used to define ‘control’ have
broad support from previous studies26 but some patients may be
satisfied with their function in spite of pain levels above those
defined on average as “unacceptable”. We suspect, though, that
even our narrow definition of ‘control’, requiring only two time
points over 3-years where pain was at ‘acceptable’ levels, results in
an optimistic estimate of symptom control. Intermittent treatment
taken during episodes of worse painwould tend to bias estimates of
‘control’ towards zero but cross-sectional estimates will still pre-
dominantly comprise long-term patterns and our choice of average
pain intensity over the past 6 months would be expected to reduce
such bias. Nevertheless, it is clear that even assuming one can apply
the Rule of Halves to symptomatic osteoarthritis, operationalizing
each step involves contentious decisions which can strongly in-
fluence the resultant estimates. We have justified our choices and
explored them through sensitivity analyses and hope to have pro-
voked critical discussion on these concepts and their definitions.
In acknowledging the challenges in applying the Rule of Halves
to symptomatic osteoarthritis, the importance of individual patient
values and needs should perhaps be emphasised. Improving pa-
tient care is not simply a case of ‘more medicine’27,28.
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